Impaired lysosomal cobalamin transport in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 43, Issue 3, 2015, Pages 1017-1030

  Zhao, Hua ^a   Li, Hongyun ^a   Ruberu, Kalani ^a   Garner, Brett ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Alzheimer's disease; amyloid ; lysosomes; neurodegeneration; vitamin B12

Indexed keywords

AMYLOID BETA PROTEIN; COBALAMIN; CYANOCOBALAMIN CO 57; PROTEASOME INHIBITOR; CYANOCOBALAMIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL ISOLATION; CELL MUTANT; CELL TRANSPORT; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; IN VITRO STUDY; IN VIVO STUDY; LYSOSOME; MALE; MITOCHONDRION; MOUSE; NONHUMAN; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BRAIN; CELL LINE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CELL LINE; LYSOSOMES; MICE; MITOCHONDRIA; VITAMIN B 12;

EID: 84914693627     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140681     Document Type: Article

References (74)

1. Weir DG, Scott JM (1999) Brain function in the elderly: Role of vitamin B12 and folate. Br Med Bull 55, 669-682.
2. Seetharam B, Yammani RR (2003) Cobalamin transport proteins and their cell-surface receptors. Expert Rev Mol Med 5, 1-18.
3. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2000) Methylmalonic acid induces excitotoxic neuronal damage in vitro. J Inherit Metab Dis 23, 355-358.
4. Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2, 425-428.
5. Cheng Y, Ren X, Hait WN, Yang JM (2013) Therapeutic targeting of autophagy in disease: Biology and pharmacology. Pharmacol Rev 65, 1162-1197.
6. Rosenblatt DS, Hosack A, Matiaszuk NV, Cooper BA, Laframboise R (1985) Defect in vitamin B12 release from lysosomes: Newly described inborn error of vitamin B12 metabolism. Science 228, 1319-1321.
7. Coelho D, Kim JC, Miousse IR, Fung S, du Moulin M, Buers I, Suormala T, Burda P, Frapolli M, Stucki M, Nurnberg P, Thiele H, Robenek H, HohneW, Longo N, Pasquali M, Mengel E,Watkins D, Shoubridge EA, Majewski J, Rosenblatt DS, Fowler B, Rutsch F, Baumgartner MR (2012) Mutations in ABCD4 cause a newinborn error of vitamin B12 metabolism. Nat Genet 44, 1152-1155.
8. Gailus S, HohneW, Gasnier B, Nurnberg P, Fowler B, Rutsch F (2010) Insights into lysosomal cobalamin trafficking: Lessons learned from cblF disease. J Mol Med 88, 459-466.
9. Williamson J, Goldman J, Marder KS (2009) Genetic aspects of Alzheimer disease. Neurologist 15, 80-86.
10. Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insights in Alzheimer's disease. Lancet Neurol 12, 92-104.
11. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer's disease. Subcell Biochem 65, 329-352.
12. WilquetV, De StrooperB(2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14, 582-588.
13. Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091.
14. Ditaranto K, Tekirian TL, Yang AJ (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 8, 19-31.
15. Chafekar SM, Baas F, Scheper W (2008) Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. Biochim Biophys Acta 1782, 523-531.
16. Zheng L, Kagedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J, Terman A (2009) Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radic Biol Med 46, 422-429.
17. Zheng L, Marcusson J, Terman A (2006) Oxidative stress and Alzheimer disease: The autophagy connection Autophagy 2, 143-145.
18. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A (2006) Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells. Ann N Y Acad Sci 1067, 248-251.
19. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A (2006) Autophagy of amyloid beta-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci Lett 394, 184-189.
20. Zheng L, Terman A, Hallbeck M, Dehvari N, Cowburn RF, Benedikz E, Kagedal K, Cedazo-Minguez A, Marcusson J (2011) Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 7, 1528-1545.
21. Langui D, Girardot N, El Hachimi KH, Allinquant B, Blanchard V, Pradier L, Duyckaerts C (2004) Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am J Pathol 165, 1465-1477.
22. Amritraj A, Hawkes C, Phinney AL, Mount HT, Scott CD, Westaway D, Kar S (2009) Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP+PS1 transgenic mouse brains. Neurobiol Aging 30, 54-70.
23. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52, 691-698.
24. Pasternak SH, Callahan JW, Mahuran DJ (2004) The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective. J Alzheimers Dis 6, 53-65.
25. Zhao H, Ruberu K, Li H, GarnerB(2014) Perturbation of neuronal cobalamin transport by lysosomal enzyme inhibition. Biosci Rep 34(1), art:e00092.doi:10.1042/BSR20130130
26. Zhao H, Brunk UT, Garner B (2011) Age-related lysosomal dysfunction: An unrecognized roadblock for cobalamin trafficking Cell Mol Life Sci 68, 3963-3969.
27. Wolfe DM, Lee JH, Kumar A, Lee S, Orenstein SJ, Nixon RA (2013) Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurosci 37, 1949-1961.
28. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146-1158.
29. Li H, Evin G, Hill AF, Hung YH, Bush AI, Garner B (2012) Dissociation of ERK signalling inhibition from the antiamyloidogenic action of synthetic ceramide analogues. Clin Sci (Lond) 122, 409-419.
30. Agholme L, Hallbeck M, Benedikz E, Marcusson J, Kagedal K (2012) Amyloid-beta secretion, generation, and lysosomal sequestration in response to proteasome inhibition: Involvement of autophagy. J Alzheimers Dis 31, 343-358.
31. Zhao H, Ruberu K, Li H, Garner B (2013) Analysis of subcellular [57Co] cobalamin distribution in SH-SY5Y neurons and brain tissue. J Neurosci Methods 217, 67-74.
32. Kim WS, LiH, Ruberu K, Chan S, ElliottDA, LowJK, Cheng D, Karl T, Garner B (2013) Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease. J Neurosci 33, 4387-4394.
33. Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, Kitago Y, Fuchtbauer EM, Fuchtbauer A, Holtzman DM, Takagi J, Willnow TE (2014) Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci Transl Med 6, 223-220.
34. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
35. Lee MJ, Lee JH, RubinszteinDC(2013) Tau degradation: The ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105, 49-59.
36. Terman A, Brunk UT (2006) Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid Redox Signal 8, 197-204.
37. Terman A, Gustafsson B, Brunk UT (2006) The lysosomalmitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 163, 29-37.
38. Kurz T, Terman A, Gustafsson B, Brunk UT (2008) Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta 1780, 1291-1303.
39. Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640, 68-80.
40. Hygum K, Lildballe DL, Greibe EH, Morkbak AL, Poulsen SS, Sorensen BS, Petersen TE, Nexo E (2011) Mouse transcobalamin has features resembling both human transcobalamin and haptocorrin. PLoS One 6, e20638.
41. Lildballe DL, Mutti E, Birn H, Nexo E (2012) Maximal load of the vitamin B12 transport system: A study on mice treated for four weeks with high-dose vitamin B12 or cobinamide. PLoS One 7, e46657.
42. Van den BergMP, Merkus P, Romeijn SG,Verhoef JC, Merkus FW (2003) Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans. J Drug Target 11, 325-331.
43. Herrmann W, Obeid R (2012) Cobalamin deficiency. Subcell Biochem 56, 301-322.
44. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16, 186-199.
45. Hook G, Yu J, Toneff T, Kindy M, Hook V (2014) Brain pyroglutamate amyloid-beta is produced by cathepsinBand is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J Alzheimers Dis 41, 129-149.
46. Herrmann W, Schorr H, Bodis M, Knapp JP, Muller A, Stein G, Geisel J (2000) Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects. Eur J Clin Invest 30, 1083-1089.
47. Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H (2002) Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58, 1539-1541.
48. Williams JH, Pereira EA, Budge MM, Bradley KM (2002) Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 31, 440-444.
49. den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM (2003) Homocysteine and brain atrophy onMRI of non-demented elderly. Brain 126, 170-175.
50. Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, de Jager C, Budge MM, Smith AD (2008) Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 71, 826-832.
51. Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, SmithAD(2013) Preventing Alzheimer's diseaserelated gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA 110, 9523-9528.
52. Gallucci M, Zanardo A, Bendini M, Di Paola F, Boldrini P, Grossi E (2014) Serum folate, homocysteine, brain atrophy, and auto-CM system: The Treviso Dementia (TREDEM) study. J Alzheimers Dis 38, 581-587.
53. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C (2008) Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 65, 642-649.
54. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One 5, e12244.
55. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD (2012) Cognitive and clinical outcomes of homocysteinelowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial. Int J Geriatr Psychiatry 27, 592-600.
56. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346, 476-483.
57. Isobe C, Murata T, Sato C, Terayama Y (2005) Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. Life Sci 77, 1836-1843.
58. Shaw LM, Korecka M, Clark CM, Lee VM, Trojanowski JQ (2007) Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 6, 295-303.
59. Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F (2010) Sadenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis 7, 373-378.
60. Morrison LD, Smith DD, Kish SJ (1996) Brain Sadenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67, 1328-1331.
61. Teunissen CE, de Vente J, Steinbusch HW, De Bruijn C (2002) Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 23, 485-508.
62. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ (2009) Hyperhomocysteinemia increases betaamyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174, 1481-1491.
63. Zhuo JM, Pratico D (2010) Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol 45, 195-201.
64. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, WilliamsSM(2006)Acontrolled trial of homocysteine lowering and cognitive performance.NEngl J Med 354, 2764-2772.
65. Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH (2007) Vitamin B6, B12, and folic acid supplementation and cognitive function: A systematic review of randomized trials. Arch Intern Med 167, 21-30.
66. Smith AD (2008) The worldwide challenge of the dementias: A role for B vitamins and homocysteine Food Nutr Bull 29, S143-S172.
67. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial. JAMA 300, 1774-1783.
68. Maron BA, Loscalzo J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60, 39-54.
69. McCaddon A (2006) Homocysteine and cognition-a historical perspective. J Alzheimers Dis 9, 361-380.
70. Andres E, Affenberger S, Vinzio S, Kurtz JE, Noel E, Kaltenbach G, Maloisel F, Schlienger JL, Blickle JF (2005) Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment. Am J Med 118, 1154-1159.
71. Nilsson-Ehle H (1998) Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy. Drugs Aging 12, 277-292.
72. Bailey LB (2004) Folate and vitamin B12 recommended intakes and status in the United States. Nutr Rev 62, S14-S20; discussion S21.
73. Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, Barberger Gateau P, Berr C, BonnefoyM, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B (2007) IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 11, 132-152.
74. Lucock MD (2006) Synergy of genes and nutrients: The case of homocysteine. Curr Opin Clin Nutr Metab Care 9, 748-756.